Obesity Clinical Trial
Official title:
Impact of Slowly Digestible Carbohydrates on the Gut-brain Axis
Verified date | April 2022 |
Source | Purdue University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Our laboratory is investigating the physiological outcomes and health benefits of the consumption of high-quality carbohydrates. One important aspect of the high-quality carbohydrate characteristics is a slow and sustained digestion and glucose release to the blood. In the proposed study, the investigators will evaluate the consumption of different types of slowly digestible carbohydrates (SDCs) and their beneficial effects including moderation of the glycemic response profile (postprandial glycemic response, PPGR) and stimulation of the gut-brain axis, which controls appetite and food intake. This stimulation will be evaluated in terms of second-meal food intake and the circulatory level of appetite-suppressing gut hormones (such as glucagon-like peptide-1).
Status | Completed |
Enrollment | 20 |
Est. completion date | February 24, 2022 |
Est. primary completion date | February 24, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 22 Years to 45 Years |
Eligibility | Inclusion Criteria: - BMI 18.5 - 25 kg/m2 - Stable weight for the past 3 months (i.e. +/- 2..5 kg) Exclusion Criteria: - Pregnant or nursing women - Diabetic - Individuals with history of gastrointestinal disease |
Country | Name | City | State |
---|---|---|---|
United States | Purdue University | West Lafayette | Indiana |
Lead Sponsor | Collaborator |
---|---|
Purdue University | Nestlé |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Postprandial glycemic response | Blood plasma glucose will be measured, (AUC) | Acute study: [4 hours of measurement after consumption of test food] | |
Primary | Postprandial glycemic response | Blood plasma glucose will be measured, (C max) | Acute study: [4 hours of measurement after consumption of test food] | |
Primary | Postprandial glycemic response | Blood plasma glucose will be measured, (t max) | Acute study: [4 hours of measurement after consumption of test food] | |
Primary | Postprandial plasma gut hormone response | Blood plasma glucagon-like peptide-1 and insulin will be measured, (AUC) | Acute study: [4 hours of measurement after consumption of test food] | |
Primary | Postprandial plasma gut hormone response | Blood plasma glucagon-like peptide-1 and insulin will be measured, (C max) | Acute study: [4 hours of measurement after consumption of test food] | |
Primary | Postprandial plasma gut hormone response | Blood plasma glucagon-like peptide-1 and insulin will be measured, (t max) | Acute study: [4 hours of measurement after consumption of test food] | |
Secondary | Gastric emptying rate | Breath test will be performed using 13C-acetate mixed into test meals | Acute study: 4 hours of measurement after consumption of test food] | |
Secondary | Appetite ratings (Visual Analog Scale, VAS) | Hunger and fullness scores will be measured using a 10-cm scale (0 = weakest feeling of hunger or fullness and 10 = strongest feeling of hunger or fullness) after consumption of test food. Weaker feelings of hunger and stronger feelings of fullness indicate better outcomes. | Acute study: [4 hours of measurement after consumption of test food] | |
Secondary | Food Intake of the next meal | At the end of the 4 hour window, participants will be given a large second meal for consumption and the amount of consumed food (food intake) will be estimated. | Acute study: After the consumption a second meal [4 hours later after consuming the first meal] | |
Secondary | Breath hydrogen (fermentability) | Breath samples will be collected in 15-minute intervals for 4 hours after consumption of test food and analyzed for hydrogen levels using a breath analyzer. Breath hydrogen levels are indicative of a food's fermentability. | Acute study: [4 hours of measurement after consumption of test food] |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |